光峯科技(688007.SH):2024年度淨利潤同比下降71.91%
格隆匯2月27日丨光峯科技(688007.SH)公佈2024年度業績快報,2024年度,公司堅定“核心技術+核心器件+應用場景”的發展戰略,通過技術優勢、產品創新化及差異化等優勢,實現營業收入24.18億元,同比增長9.27%,保持穩健增長態勢;其中,車載光學業務於2024年進入密集量產交付階段,實現營業收入超6億元。
報吿期內,歸屬於母公司所有者的淨利潤2898.33萬元,同比下降71.91%;公司主動調整C端業務經營策略並加快清理C端庫存,C端業務收入佔比和毛利率均有所下降,公司車載業務進入密集交付期,該業務佔比持續提升,車載業務毛利率較低於影院、專顯等業務的毛利水平,導致整體毛利率下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.